Clinical Trials
We are committed to pushing the boundaries of clinical trials and ensuring the highest standards of safety and care. Join us as we embark on the exciting journey of scientific exploration and medical advancement.
Currently Enrolling Participants for:
Current Active Studies
No Longer Enrolling
A Phase 3 randomized, multi-center, placebo-controlled, masked Study to evaluate the clinical efficacy and safety of Fucithalmic® (Fusidic Acid 1%) Viscous Topical Antibiotic Eye Drops for the treatment of suspected bacterial conjunctivitis.
A Phase IIb, randomized, observer-blind study to describe the safety, tolerability, and immunogenicity of MenABCWY administered on different dosing schedules in healthy adolescents.
A Phase 3a, observer-blind, randomized, controlled study to demonstrate lot-to-lot consistency and evaluate the immunogenicity and safety of an investigational varicella vaccine compared with Varivax, administered as a first dose to healthy children 12 to 15 months of age.
A Master Phase 1/2/3 protocol to investigate the safety, tolerability, and immunogenicity of Variant-Adapted BNT162b2 RNA-Based vaccine candidate(s) in healthy children.
A phase 2, randomized, double-blind trial to evaluate the safety, tolerability, and immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in healthy infants.
Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 2-arm study to investigate the safety of a 4-dose regimen of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers.